The Miriam Hospital is a private, not-for-profit hospital at 164 Summit Avenue in Providence, in the U.S. state of Rhode Island. It is a major teaching affiliate of the Warren Alpert Medical School of Brown University.

There are 247 beds in The Miriam Hospital.

During the past decade, The Miriam Hospital conducted 129 clinical trials. In the 10-year time frame, 129 clinical trials started and 105 clinical trials were completed, i.e. on average, 81.4% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 42 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Miriam Hospital" #1 sponsor was "The Miriam Hospital" with 56 trials, followed by "Alliance for Clinical Trials in Oncology" with 53 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 35 trials sponsored, "Brown University" with 23 trials sponsored and "National Cancer Institute (NCI)" with 23 trials sponsored. Other sponsors include 179 different institutions and companies that sponsored additional 112 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Miriam Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "Rhode Island Hospital" with 25 trials as a collaborator, "The Miriam Hospital" with 24 trials as a collaborator, "Brown University" with 15 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 15 trials as a collaborator. Other collaborators include 259 different institutions and companies that were collaborators in the rest 157 trials.

According to Clinical.Site data, the most researched conditions in "The Miriam Hospital" are "HIV Infections" (69 trials), "Lung Cancer" (17 trials), "Obesity" (16 trials), "Coronary Artery Disease" (13 trials) and "Breast Cancer" (11 trials). Many other conditions were trialed in "The Miriam Hospital" in a lesser frequency.

Most popular intervention types in "The Miriam Hospital" are "Drug" (192 trials), "Behavioral" (69 trials), "Other" (63 trials), "Biological" (54 trials) and "Device" (41 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Placebo" (20 trials), "Quality-of-Life Assessment" (14 trials), "Lamivudine" (10 trials) and "gemcitabine hydrochloride" (9 trials). Other intervention names were less common.

The vast majority of trials in "The Miriam Hospital" are 324 trials for "All" genders, 34 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 74 active trials in "The Miriam Hospital". 1 are not yet recruiting, 27 are recruiting, 45 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 249 completed trials in The Miriam Hospital, 2 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in The Miriam Hospital, 32 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 99 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 109 trials that are defined as “Not Applicable".